Podcast: No Patient Left Behind: Connecting Rare Disease Patients to Orphan Drug Manufacturers

Share this content:




Marc Iskowitz (top), MM&M's editor in chief, discusses a qualitative/quantitative approach to meeting orphan drug marketers' engagement challenge with Michael Carlin (bottom), VP of virtual engagement at TrialCard.

Click here to download the white paper: "No Patient Left Behind: Connecting Rare Disease Patients to Orphan Drug Manufacturers."

Share this content:
Scroll down to see the next article